Literature DB >> 11239519

Role of lipids, lipoproteins and vitamins in women with breast cancer.

G Ray1, S A Husain.   

Abstract

OBJECTIVES: Improper balance between the production of reactive oxygen metabolites (ROMs), and antioxidative defense system have been defined as oxidative stress in various pathologic conditions. Lipids, lipoproteins and antioxidative vitamins have been associated with the risk of breast cancer. The present case-control study was conducted to investigate the status of antioxidative vitamins (A, C and E), lipids (total cholesterol; TC and triglycerides; TG), lipoproteins (high-density lipoprotein cholesterol; HDL-C and low-density lipoprotein cholesterol; LDL-C) and retinol-binding protein (RBP) in breast cancer patients. The aim of the study was to find out oxidative stress in breast cancer. DESIGN AND METHODS: Plasma lipids, lipoproteins and vitamins were estimated in 54 untreated breast cancer patients of different clinical stages and in 42 age- and sex-matched controls.
RESULTS: Plasma TC (p < 0.05), and LDL-C and TG (p < 0.01) were found to be significantly elevated among breast cancer patients as compared to the controls. On the other hand, plasma HDL-C concentration (p < 0.001) and vitamin C and E (p < 0.01) were observed significantly decreased in breast cancer patients than in the controls. The maximum changes in plasma TC, and vitamin C and E concentrations were observed in breast cancer patients with stage IV when compared with controls.
CONCLUSION: The study suggests that higher levels of TC and TG may play important role in carcinogenesis. Furthermore, the elevated plasma LDL-C concentration, which is more susceptible to oxidation, may result in higher lipid peroxidation in breast cancer patients. However, decreased concentrations of HDL-C and vitamin C and E are not likely to be sufficient enough to counter higher ROMs production reported earlier in breast cancer patients that may cause oxidative stress leading to cellular and molecular damage thereby resulting in cell proliferation and malignant conversions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239519     DOI: 10.1016/s0009-9120(00)00200-9

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  41 in total

1.  High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer.

Authors:  Adam R Wolfe; Rachel L Atkinson; Jay P Reddy; Bisrat G Debeb; Richard Larson; Li Li; Hiroko Masuda; Takae Brewer; Bradley J Atkinson; Abeena Brewster; Naoto T Ueno; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

Review 2.  The metabolic syndrome: A high-risk state for cancer?

Authors:  Stephanie Cowey; Robert W Hardy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

3.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression.

Authors:  Fulan Hu; Zhiwei Wu; Guangxiao Li; Chong Teng; Yupeng Liu; Fan Wang; Yashuang Zhao; Da Pang
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-15       Impact factor: 4.553

6.  Serum total oxidant/antioxidant status and trace element levels in breast cancer patients.

Authors:  Jia-Fu Feng; Ling Lu; Ping Zeng; Yun-Hong Yang; Jun Luo; Yu-Wei Yang; Dong Wang
Journal:  Int J Clin Oncol       Date:  2011-10-05       Impact factor: 3.402

7.  High plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies.

Authors:  Hai-Qing Yang; Fa-Qi Qiu; K E Jin; Neng-Gang Jiang; L I Zhang
Journal:  Exp Ther Med       Date:  2015-03-27       Impact factor: 2.447

8.  Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour.

Authors:  Elteza Tahjiba Jahir; Runi Devi; Bibhuti Bhushan Borthakur
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients.

Authors:  Kostas Christou; Nikolaos Markoulis; Anargyros N Moulas; Chaido Pastaka; Kostantinos I Gourgoulianis
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

10.  Assessment of YKL-40, lipid profile, antioxidant status, and some trace elements in benign and malignant breast proliferation.

Authors:  Eman M Shahy; Mona M Taha; Khadiga S Ibrahim
Journal:  Mol Biol Rep       Date:  2020-09-02       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.